Genactis

Executive Summary

Genactis is a Germany-based healthcare insights and market research firm serving the pharmaceutical and biotech sectors. Founded in 2018 and headquartered in Munich, the company operates a global, verified physician panel of over 18,000 doctors across 40 countries. Its core offering is generating strategic commercial intelligence for clients through qualitative and quantitative studies, enabling data-driven decision-making in drug development, launch, and lifecycle management. By providing primary market research services, Genactis helps pharmaceutical and biotech companies understand market dynamics, physician prescribing behaviors, and patient journeys. Despite being categorized under CRISPR and Synthetic Biology, the company's actual operations are focused on market research and physician panels, positioning it as a specialized service provider in the healthcare intelligence space.

Upcoming Catalysts (preview)

• Q4 2026Expansion of physician panel into new therapeutic areas60% success
• Q1 2027Strategic partnership with a major pharmaceutical company for syndicated reports45% success